Literature DB >> 23937784

The promise and pitfalls of genomics-driven cancer medicine.

Erin W Hofstatter1, Allen E Bale.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23937784     DOI： 10.1001/virtualmentor.2013.15.8.stas1-1308

Source DB:  PubMed          Journal:  Virtual Mentor        ISSN： 1937-7010


× No keyword cloud information.
  3 in total

Review 1.  Clinicians' expectations for gene-driven cancer therapy.

Authors:  Antti Jekunen
Journal:  Clin Med Insights Oncol       Date:  2014-12-18

Review 2.  Proteomic approaches for characterizing renal cell carcinoma.

Authors:  David J Clark; Hui Zhang
Journal:  Clin Proteomics       Date:  2020-07-29       Impact factor: 3.988

3.  The Role of Medical Mistrust in Concerns about Tumor Genomic Profiling among Black and African American Cancer Patients.

Authors:  Ariel Hoadley; Sarah Bauerle Bass; Yana Chertock; Jesse Brajuha; Paul D'Avanzo; Patrick J Kelly; Michael J Hall
Journal:  Int J Environ Res Public Health       Date:  2022-02-23       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.